- Powerful, cost-effective system configurable for all clinical needs
- AI-powered applications optimize efficiency
- Ideal for emerging markets and smaller healthcare centers
Siemens Healthineers has introduced the ACUSON Maple, a powerful, versatile, and affordable ultrasound system that enables rapid diagnosis and assessment in all clinical settings. Artificial intelligence (AI)-powered features optimize everyday clinical performance for users of all skill levels.
Powered by ACUSON technology from the company’s established portfolio, the ACUSON Maple is designed for the clinician who needs a workhorse ultrasound system that supports a diverse range of ultrasound use cases. Lightweight, portable, and battery-powered, the ACUSON Maple is ideal for emerging markets, small hospitals, outpatient centers, private practices, and urgent care centers.
“Siemens Healthineers proudly expands its ACUSON portfolio with the ACUSON Maple, which leverages a common hardware and software platform as well as AI-powered1 applications that automate workflow and analysis to bolster exam efficiency,” said Daniel Frisch, head of radiology and image guidance at Siemens Healthineers Ultrasound. “This affordable, configurable, and versatile system offers a broad range of diagnostic imaging capabilities, with a high level of image quality for every patient.”
Designed for versatility, the ACUSON Maple supports 15 transducers and has 25 advanced features that enhance usability and streamline workflow. An integrated battery enables up to 75 minutes of unplugged system scanning. This capability is invaluable in emerging markets with power supply challenges and in clinical settings that require movement between exam rooms for rapid patient assessment.
The system’s suite of AI-powered tools1 empowers clinicians to improve efficiency by increasing consistency in repetitive tasks. For obstetrics and gynecology (OB/GYN) imaging, the Auto OB feature leverages machine learning to automatically calculate the fetus’s age and weight, reducing overall measurement time by up to 24%2. For cardiac imaging, the eSie Measure feature uses machine learning to automatically perform cardiac measurements during a routine echocardiography exam. eSie Measure reduces keystrokes by up to 44% and shortens routine echo exam time by up to five minutes3.
The ultrasound system is cleared by the U.S. Food and Drug Administration, CE marked in the European Union, and is available globally.
For further information on the ACUSON Maple, visit https://www.cassling.com/products-and-solutions/imaging/ultrasound/acuson-maple.
Contact for journalists
Phone:+484-868-8346; E-mail: email@example.com
About Siemens Healthineers
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at www.siemens-healthineers.com.
Meet the Author
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology.